The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1084/jem.20061563
The Journal of Experimental Medicine, Vol. 203, No. 13, 2793-2799
The Rockefeller University Press, 0022-1007 $30.00
© Shreeram et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1218K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shreeram, S.
Right arrow Articles by Bulavin, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shreeram, S.
Right arrow Articles by Bulavin, D. V.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Medline Plus Health Information
*Lymphoma
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

BRIEF DEFINITIVE REPORT

 Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase

Sathyavageeswaran Shreeram1, Weng Kee Hee1, Oleg N. Demidov1, Calvina Kek1, Hiroshi Yamaguchi2, Albert J. Fornace, Jr.3, Carl W. Anderson4, Ettore Appella2, and Dmitry V. Bulavin1

1 Institute of Molecular and Cell Biology, Singapore, 138673
2 Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892
3 Department of Genetics and Complex Diseases, Harvard School Of Public Health, Boston, MA 02115
4 Biology Department, Brookhaven National Laboratory, Upton, NY 11973

CORRESPONDENCE D.V. Bulavin: dvbulavin{at}imcb.a-star.edu.sg

The ataxia telangiectasia mutated (ATM) kinase is a key tumor suppressor that regulates numerous cell cycle checkpoints as well as apoptosis. Here, we report that ATM is a critical player in the regulation of apoptosis and lymphomagenesis in the presence of c-myc. In turn, deletion of the inhibitory ATM phosphatase, Wip1, results in ATM up-regulation and suppression of Eµ-myc–induced B cell lymphomas. Using mouse genetic crosses, we show that the onset of myc-induced lymphomas is dramatically delayed in Wip1-null mice in an ATM- and p53-, but not p38 MAPK– or Arf-, dependent manner. We propose that Wip1 phosphatase is critical for regulating the ATM-mediated tumor surveillance network.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS